サウスカロライナにおける卵巣がんの臨床試験
サウスカロライナ内の拠点で、卵巣がんに関する17件の研究が参加者を募集しています。
サウスカロライナ内の都市
公式研究テキスト（英語）
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- Prisma Health Cancer Institute - Spartanburg, Boiling Springs
- Prisma Health Richland Hospital, Columbia
- Prisma Health Cancer Institute - Easley, Easley
- 他8件
被験者募集中第2相
全年齢 · 全性別 · 2026/10/05更新 · NCT05564377A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
- Medical University of South Carolina, Charleston
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07213804Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
- PRISMA Health/ITOR, Greenville
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/21更新 · NCT05983432A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
- Medical University of South Carolina, Charleston
被験者募集中第2相
18歳〜99歳 · 女性 · 2026/09/15更新 · NCT07023627ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Carolina Urologic Research Center, Myrtle Beach
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/14更新 · NCT05059444FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
- Spartanburg Regional, Spartanburg
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/14更新 · NCT06303505Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
- Hollings Cancer Center, Charleston
被験者募集中第3相
18歳以上 · 女性 · 2026/08/26更新 · NCT05281471A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
- Normunity Investigational Site, Charleston
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/18更新 · NCT07182149A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
- Saint Joseph's/Candler - Bluffton Campus, Bluffton
- Medical University of South Carolina, Charleston
- Gibbs Cancer Center-Gaffney, Gaffney
- 他6件
被験者募集中
35歳〜50歳 · 女性 · 2026/08/07更新 · NCT04251052Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- Gibbs Cancer Center-Gaffney, Gaffney
- Gibbs Cancer Center-Pelham, Greer
- Spartanburg Medical Center, Spartanburg
- 他1件
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/07更新 · NCT06580314A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
- Medical University of South Carolina (MUSC), Charleston
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/07/28更新 · NCT06161025DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
- USA03-0, Charleston
被験者募集中第2相
18歳以上 · 全性別 · 2026/05/22更新 · NCT06953089Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
- Medical University of South Carolina (Hollings Cancer Center), Charleston
被験者募集中第3相
18歳以上 · 女性 · 2026/04/16更新 · NCT05659381cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Medical University of South Carolina, Charleston
- McLeod Health, Florence
被験者募集中観察研究健康なボランティア歓迎
40歳以上 · 全性別 · 2026/01/20更新 · NCT05366881A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
- Dren Investigational Site, Greenville
被験者募集中第1相
18歳以上 · 全性別 · 2026/01/07更新 · NCT06999187Autophagy Maintenance (AUTOMAIN)
- Medical University of South Carolina, Charleston
被験者募集中第2相
18歳以上 · 全性別 · 2025/12/22更新 · NCT06971744SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Greenville
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。